Related Experiment Video
Updated: May 24, 2025

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity
Published on: January 7, 2019
LncRNA MALAT1/Calpain-1 Axis in ATO Induced hERG Channel Deficiency
Caichuan Yan1, Yuexin Li1, Xiaoxu Li1
1Department of Pharmacology, College of Pharmacy, Harbin Medical University, Harbin, People's Republic of China.
Arsenic trioxide (ATO) causes cardiotoxicity by increasing MALAT1, which activates calpain-1 and reduces hERG channels. Tanshinone IIA and fexofenadine counteract this, offering potential treatments for acquired long QT syndrome (acLQTS).
Area of Science:
- Cardiovascular Pharmacology
- Molecular Biology
- Oncology
Background:
- KCNH2 (human ether-à-go-go-related gene) encodes the hERG potassium channel, crucial for cardiac repolarization.
- Acquired long QT syndrome (acLQTS) is a serious side effect of certain drugs, including arsenic trioxide (ATO), used to treat acute promyelocytic leukemia.
- ATO-induced cardiotoxicity can lead to life-threatening arrhythmias like torsade de pointes (TdP).
Purpose of the Study:
- Investigate the role of long noncoding RNA MALAT1 in ATO-induced acLQTS.
- Elucidate the molecular mechanisms underlying ATO's cardiotoxic effects.
- Identify potential therapeutic agents to mitigate ATO-induced cardiotoxicity and target interventions for acLQTS.
Main Methods:
- Gene chip arrays to identify dysregulated long noncoding RNAs (lncRNAs).
- Quantitative qRT-PCR and RNA-binding protein immunoprecipitation (RIP) to analyze lncRNA expression and interactions.
- Western blotting for protein analysis and whole-cell patch-clamp recordings to assess hERG channel function.
Main Results:
- Arsenic trioxide (ATO) significantly upregulated MALAT1 expression in cells expressing the hERG channel.
- MALAT1 was found to interact with calpain-1, inhibiting its degradation and enhancing its activity towards the hERG channel.
- Fexofenadine (FEX) and Tanshinone IIA (TAN) mitigated ATO's effects on the MALAT1/calpain-1 pathway, restoring hERG protein levels.
Conclusions:
- ATO-induced cardiotoxicity and hERG channel reduction are associated with MALAT1 overexpression and enhanced calpain-1 activity.
- Tanshinone IIA and fexofenadine may restore hERG levels by reducing MALAT1 expression and counteracting ATO's effects on the MALAT1/calpain-1 pathway.
- This study reveals a novel regulatory mechanism for ATO-induced acLQTS and identifies MALAT1, calpain-1, and potential therapeutic agents as targets for intervention.
More Related Videos
10:45Isolation of Human Myoblasts, Assessment of Myogenic Differentiation, and Store-operated Calcium Entry Measurement
Published on: July 26, 2017
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
Related Concept Videos
lncRNA - Long Non-coding RNAs
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
G-Protein Gated Ion Channels
Sensory...